Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 5, 2026 Off

Best Male Enhancement Pills 2026: Launched By Performer 8′ Over The Counter ED Pills For Erectile Dysfunction, Growth & Last Longer for Men

By GlobeNewswire

best male enhancement pills sold in stores’ Pills for Erectile dysfunction for men, Effective Formula for last longer and testosterones…

January 5, 2026 Off

Best Over The counter Sleep Aid 2026: Launched By NooCube Strongest natural sleep aid, Pills For Sleep And Anxiety Without Side effects

By GlobeNewswire

Strongest sleep aid over the counter sleep Pills NooCube best for sleep and anxiety read side effects, benefits, ingredients of…

January 5, 2026 Off

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

By GlobeNewswire

SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host…

January 3, 2026 Off

Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

By GlobeNewswire

NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical…

January 3, 2026 Off

Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026

By GlobeNewswire

TARRYTOWN, N.Y., Jan. 02, 2026 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its…

January 2, 2026 Off

Mesoblast Announces Changes to Board of Directors’ Leadership Roles

By GlobeNewswire

NEW YORK, Jan. 01, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…

January 1, 2026 Off

XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update

By GlobeNewswire

Clinical Data doubles known genetic factors associated with urate and GoutCALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics…

January 1, 2026 Off

Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

By GlobeNewswire

NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical…

January 1, 2026 Off

Alvotech Secures Term Loan Facility of USD 100 Million

By GlobeNewswire

USD 100 million senior term loan facility with a 2-year maturityStrengthens liquidity to support execution across Alvotech’s R&D pipeline and…

January 1, 2026 Off

Alvotech Secures Term Loan Facility of USD 100 Million

By GlobeNewswire

USD 100 million senior term loan facility with a 2-year maturityStrengthens liquidity to support execution across Alvotech’s R&D pipeline and…

Posts pagination

Previous 1 … 23 24 25 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine